Glorioso, Joseph C.

The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease

Koldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry

Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism

Cited by 279

Gene Delivery Using Herpes Simplex Virus Vectors

Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology

Virus-based gene therapy researchHerpesvirus Infections and Treatments

Cited by 92

A brief account of viral vectors and their promise for gene therapy

Finer, M., & Glorioso, J. (2017) · Gene Therapy

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 79

Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts

McTiernan, C. F., Mathier, M. A., Zhu, X., Xiao, X., Klein, E., Swan, C. H., Mehdi, H., Gibson, G., Trichel, A. M., Glorioso, J. C., et al. (2007) · Gene Therapy

Virus-based gene therapy researchViral Infections and Immunology Research

Cited by 40

Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.

Frampton, A. R., Goins, W. F., Cohen, J. B., von Einem, J., Osterrieder, N., O'Callaghan, D. J., & Glorioso, J. C. (2005) · Journal of Virology

Herpesvirus Infections and TreatmentsAnimal Virus Infections Studies

Cited by 36

Moving toward a gene therapy for Huntington’s disease

Glorioso, J. C., Cohen, J. B., Carlisle, D. L., Munoz-Sanjuan, I., & Friedlander, R. M. (2015) · Gene Therapy

Genetic Neurodegenerative DiseasesVirus-based gene therapy research

Cited by 20